Covington Represents Catalio Capital Management in $20 Million Credit Investment in Amalgam Rx

WASHINGTON—Covington advised Catalio Capital Management LP in its $20 million credit investment in Amalgam Rx, Inc.

The senior secured term loan provides Amalgam with an initial draw of $12 million at close to continue its market expansion and refinance existing corporate debt.

Catalio Capital Management is a New York-based investment firm focused on the full lifecycle of innovative healthcare investing across private, public and credit markets. Catalio has exclusive partnerships with serial scientist-entrepreneurs from around the globe who have started multiple well-established companies based on their research.

Amalgam Rx empowers patients and providers to make the best decisions possible—within clinical workflows and in everyday life. With a modular SaMD platform, EHR solutions, and Medical-Grade Al, Amalgam partners with global life sciences companies, health plans, and providers to reimagine care delivery.

The Covington team was led by Brent Little, Matthew Foster, and Nancy Rich.